Your browser doesn't support javascript.
loading
Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.
Becker, Russell E N; Meyer, Alexa R; Brant, Aaron; Reese, Adam C; Biles, Michael J; Harris, Kelly T; Netto, George; Matoso, Andres; Hoffman-Censits, Jean; Hahn, Noah M; Choi, Woonyoung; McConkey, David; Pierorazio, Phillip M; Johnson, Michael H; Schoenberg, Mark P; Kates, Max R; Baras, Alex; Bivalacqua, Trinity J.
Afiliación
  • Becker REN; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA. Electronic address: rbecker@jhmi.edu.
  • Meyer AR; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Brant A; Department of Urology, Weill Cornell Medicine, New York, NY, USA.
  • Reese AC; Department of Urology, Temple Health, Philadelphia, PA, USA.
  • Biles MJ; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Harris KT; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Netto G; Department of Urology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Matoso A; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Hoffman-Censits J; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Hahn NM; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Choi W; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • McConkey D; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Pierorazio PM; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Johnson MH; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Schoenberg MP; Department of Urology, Montefiore Medical Center, Bronx, NY, USA.
  • Kates MR; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Baras A; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
  • Bivalacqua TJ; The Greenberg Bladder Cancer Institute & James Buchanan Brady Urological Institute, Johns Hopkins Medicine, Baltimore, MD, USA.
Eur Urol ; 79(3): 364-371, 2021 03.
Article en En | MEDLINE | ID: mdl-32814637
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Terapia Neoadyuvante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2021 Tipo del documento: Article